265
DAYS
265
DAYS
0
HOURS
0
MINUTES
0
SECONDS
We have started!
Watch the live stream
Promote synergy between HIV prevention science and program.
Maximize the impact of HIV prevention on HIV incidence, access to care, and health equity.
Accelerate the diffusion of best and promising HIV prevention practices, policies and research.
Forge new connections across the full range of HIV prevention and care providers,
researchers, policy makers, advocates, and people living with and affected by HIV.
A mult-functional 4500-seater auditorium that can be partitioned into 4 separate individual sound-proofed rooms with simultaneous interpretation facilities for up to 11 languages.
Provide participants with the opportunity to learn more about what works for HIV prevention.
Creation of much needed platform for interaction between African researchers, scientists and community advocates to discuss the issues of HIV prevention and the response on the continents.
Dr. Nelly R. Mugo
Kenya Medical Research Institute (KEMRI), Nairobi.
PreP: What the future holds for Africa
09:00am - 09:30am
Dr. Nelly R. Mugo is an obstetrician, gynecologist and a principal research scientist at the Kenya Medical Research Institute (KEMRI), Nairobi. She has spent the last 16 years in clinical research with a focus in HIV prevention and reproductive health research. Presently, she collaborates with the University of Washington, International Clinical Research Center (ICRC); department of global health in conduct of HIV-1 prevention clinical research and she is the principal investigator for Partners in Health Research Development (PHRD) and the Partners PrEP Demonstration project, Thika site. She is an author and has so far done over 65 peer review journal publications.
Thumbi Ndung'u
University of KwaZulu-Natal
HIV Vaccine research and implication for HIV control in Africa
09:30am - 10:00am
Thumbi Ndung’u is an Investigator and Max Planck Institute for Infection Biology Research Group Leader at the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH). He is Professor and Victor Daitz Chair in HIV/TB Research and Director of the HIV Pathogenesis Programme (HPP) at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal. He holds the South African Research Chair in Systems Biology of HIV/AIDS. He is also a Howard Hughes Medical Institute International Early Career Scientist. He graduated with a Bachelor of Veterinary Medicine degree from the University of Nairobi, Kenya, and obtained a PhD in Biological Sciences in Public Health (Virology) from Harvard University, United States. His research interests are host-pathogen interactions, especially antiviral immune responses. He is leading a multidisciplinary team of researchers working in the fields of HIV and TB pathogenesis and vaccine development. He has special interest in capacity building for biomedical research in Africa.
Prof. Zvavahera Mike Chirenje
College of Health Sciences,University of Zimbabwe
Updates on ARV and non-ARV based microbicide research
10:00am - 10:30am
Zvavahera Mike Chirenje, MD, FRCOG, is a Professor in the Department of Obstetrics and Gynecology at the College of Health Sciences at the University of Zimbabwe. He is an attending Gynecological Oncologist at Parirenyatwa Hospital in Harare, Zimbabwe. He also conducts HIV prevention clinical trials in women with a particular emphasis on microbicide and Pre-Exposure Prophlyaxis (PrEP) development. He was one of the founding members of the University of Zimbabwe - University of California, San Francisco (UZ-UCSF) Collaborative Research Programme in Women’s Health, and has served as the Executive Director since 2002. He provides fiscal, operational, and scientific oversight of a complex research unit that employs over 280 staff and research investigators. For the last 25 years, Dr. Chirenje has been Director for the UZ - UCSF Dysplasia Clinic at Spilhaus Clinical Research Site in Harare where he has introduced digital colposcopy, loop excision treatment and cyrotherapy training syllabus for VIA workshops. He is chair of the Mentored Research Scholarship Program at the University of Zimbabwe.
Patrick Eba
Senior Human Rights and Law Adviser at UNAIDS
Elimination of HIV infection: global engagement with the realities for Africa
11:30am - 11:50am
Patrick Eba is Senior Human Rights and Law Adviser at UNAIDS in Geneva where he advises UNAIDS country and regional offices, as well as governments and civil society on human rights issues relating to the HIV response. At UNAIDS, Patrick is the focal person for the organisation’s work on criminalisation of people living with HIV and members of key populations, including sex workers and LGBT people. He is also the focal person for UNAIDS’ work with Parliaments and the Judiciary. He is an independent expert member on the Committee on the Rights of People Living with HIV, those at risk and vulnerable to HIV of the African Commission on Human and Peoples’ Rights. Before joining UNAIDS in Geneva, Patrick worked on human rights and legal issues in Côte d’Ivoire, Malawi, South Africa and Senegal.
George Owino
International AIDS Vaccine Initiative (IAVI)
Key population and HIV research in Africa
11:50am - 12:10pm
George Victor Owino is the Program Associate for East and Southern Africa at the International AIDS Vaccine Initiative (IAVI) a global not-for-profit organization where he provides expertise and leadership for the key populations program, in addition to programmatic support for research preparedness and external relations functions. Previously was the Director and head Programs, Research and Outreach and founder member of Professionals in Pride Kenya; where he led the groundbreaking socio-behavioral and structural research programs. He has also served as project coordinator at Ishtar, board member of GALCK, co-chair of the MSMGF Youth Reference Group and currently board chair of PPK.
Dr Francis Cowan
Executive Director of the Trust
ART prevention among young women
12:10pm - 12:30pm
Dr Francis Cowan is a clinical epidemiologist who has been living and working full time in Zimbabwe since 1999. She leads a large portfolio of HIV prevention and sexual and reproductive health research including several clinical trials and impact evaluations of national programmes. The group works closely with the Zimbabwe Ministry of Health and Child Care and the National AIDS Council to undertake research to facilitate intervention scale up and inform the evidence base for their HIV prevention and care policies and programming. She oversees implementation of Zimbabwe’s National Sex Work Programme ‘Sisters with a Voice’ now operating in 36 sites across Zimbabwe. Her research group consists of 60-100 staff (depending on stage of research implementation), with a core staff of 10 mid-level researchers, 3 of whom are enrolled as PhD students at UCL. In 2012, she registered the research group as a not for profit Trust (CeSHHAR ZImbabwe). She is the Executive Director of the Trust and Principal Investigator of all the research projects that it currently supports.
Rosemary Mburu
World AIDS Campaign
Making the needed difference: An African CSO agenda for NPT Advocacy
12:30pm - 12:50pm
Rosemary W. Mburu is the Executive Director for World AIDS Campaign International (WACI). Previously she worked for Kenya AIDS NGOs Consortium (KANCO). She has over ten years of international experience in areas of public health research, programming and advocacy. Mburu is a civil society organizer who has extensively worked on building and strengthening civil society networks and platforms on health-related advocacy and campaigning in Africa. Her current role involves civil society organizing towards a united African civil society voice and action to influence political decisions for increased resources for health. Ms. Mburu Holds a Masters in Public Health from Ohio University, a Masters in Business Administration from Frostburg State University, Maryland, and a Bachelor of Education from Kenyatta University, Kenya. Some of her published work include: The Abuja +12 declaration: implications for HIV response in Africa.; How ethical is your clinical trial?; Getting to zero the biomedical way in Africa: outcomes of deliberation at the 2013 Biomedical HIV Prevention Forum in Abuja, Nigeria
Elizabeth Bukusi
Senior Research Officer at Kenya Medical Research Institute
2:00pm - 3:00pm
Since, 1995, Dr. Bukusi has served as the Co-Director of the UCSF-Kenya Medical Research Institute's collaborative Research Care and Treatment Program (RCTP). Since 2004, she has been co-PI of the CDC/PEPFAR-funded Kenya-based Family AIDS Care and Education Services (FACES) HIV care and support program. As part of FACES and in collaboration with Dr. Craig Cohen, she developed the Student Training Elective Program (STEP), which places medical students and residents in FACES clinics. She has over 15 years experience conducting research in HIV prevention, care, and treatment among women and men in Kenya. Her research focuses on development of HIV prevention technologies, HIV care and treatment, and ethics in research. Dr. Bukusi's training in Medicine and Obstetrics and Gynecology is from the University of Nairobi; her training in Epidemiology and Public Health are from the University of Washington; and here training in research ethics is from the University of Cape Town School of Medicine. She is currently a Chief research officer and deputy Director Research and Training at Kenya Medical Research Institute and holds a honorary faculty appointment in the Department of Obstetrics and Gynaecology at the University of Nairobi. She is also an Associate Professor in University of Washington, Department of Obstetrics and Gynecology.
The forum will update stakeholders present at the forum on new issues and development with the HIV prevention research especially as it affects the continent. It shall create the much needed platform for interaction between African researchers, scientists and community advocates to discuss the issues of HIV prevention and the response on the continents. Synthesis of HIV prevention issues discussed at this forum will inform
These outcomes shall be developed as policy briefs and circulated to all relevant stakeholders within 3 months of the end of the conference. Over the next two years, the Forum organisers shall use the documents as advocacy and monitoring tools. The actions derivable from this shall be part of the report presented at the next forum.
44B, Ijaiye Road, Ogba,
Lagos, Nigeria.
info@nhvmas-ng.org